Industry

News

March 21, 2024

A Johns Hopkins scientist was known for rigorous studies of psychedelics. Was he a true believer?

February 28, 2024

As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments

With the stage set for the first psychedelic-based therapy to nab FDA approval this year, even J.P. Morgan can't resist the allure of compelling data and wide-open markets.

February 28, 2024

New Research Grants Push Psychedelic Studies Beyond Therapeutics

The study of psychedelics within academic institutions is nothing new. Over the decades, almost all of the research funding has been for the therapeutic application of psychedelics in society.

February 10, 2024

Investors pile into psychedelic drug start-ups tackling mental health

February 8, 2024

Massachusetts Lawmakers Approve Psilocybin Bill To Legalize For ‘Therapeutic, Spiritual And Medicinal Purposes’

With a psychedelics legalization initiative pending before lawmakers ahead of a potential vote on the November ballot

February 6, 2024

The Working Woman’s Newest Life Hack: Magic Mushrooms

For a select group of moms in high-powered jobs, psilocybin has become the answer to a packed social and professional calendar with no time for hangovers

February 5, 2024

As investors pile into psychedelics, idealism gives way to pharma economics

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions.

February 4, 2024

What Does Being Sober Mean Today? For Many, Not Full Abstinence.

February 3, 2024

Idealism gives way to pharma economics as investors rush into psychedelic market

January 19, 2024

Your employer may be adding another health benefit to its roster: psychedelic drugs

An increasing number of employers are giving their workers access to psychedelic-assisted therapy as part of their health plan.

November 29, 2023

The Evolutionary Origins of Psychedelics

Lately, though, some have also turned to psychedelics like psilocybin to change their perspectives. In fact, researchers are beginning to test if they could serve as new treatments for mental health disorders.

November 15, 2023

Health Benefits Provider Will Cover Psilocybin-Assisted Therapy In States Where It’s Legal

A Massachusetts company that bills itself as “the first and only licensed provider of psychedelic health plans” announced on Tuesday that it will cover psilocybin-assisted therapy in states where it’s legal.

November 7, 2023

Ohio Issue 2 to legalize recreational marijuana passes

Voters in Ohio have approved an initiative to become the 24th state in the nation to legalize recreational marijuana, the Associated Press has projected.

November 2, 2023

Senate Votes To Allow VA Doctors To Recommend Medical Marijuana To Veterans, Similar To House-Passed Version

The Senate has approved a bill that includes an provision to allow doctors at the U.S. Department of Veterans Affairs (VA) to issue medical marijuana recommendations to veterans living in legal states

October 26, 2023

Marijuana Businesses Seek to Make Federal Restrictions Go Up in Smoke

Lawsuit filed by superlawyer David Boies challenges federal power, Supreme Court precedent

October 23, 2023

A New Era of Psychedelics in Oregon

The state has pioneered a therapeutic market for psychedelic mushrooms. Researchers are watching with a mix of excitement and unease.

October 17, 2023

Inside a Psychedelic Retreat for the Corporate Elite

Can toxic company culture be cured with mushrooms? A growing movement of leaders in the business world are willing to give it a shot.

October 13, 2023

House speaker chaos, other priorities complicate cannabis banking bill

The legislation passed a key Senate committee in late September. Expected full Senate passage would be another historic first.

October 10, 2023

FDA warns patients and health care providers about potential risks associated with compounded ketamine products

There is increased interest in compounded ketamine products (including oral formulations) for the treatment of psychiatric disorders.

October 2, 2023

Cannabis-infused seltzer brand Happi hopes to live up to its name

Happi, a cannabis-infused seltzer company founded in 2021, is bringing a whole new meaning to the word “happy.”

September 27, 2023

U.S. Senate Committee Approves Bipartisan Marijuana Banking Bill, Sending It To The Floor

The Senate Banking Committee has approved a bipartisan marijuana banking bill with amendments, sending it to the floor.

September 18, 2023

Rescheduling Misconceptions and Responses

September 15, 2023

Thousands sign up to experience magic mushrooms as Oregon's novel psilocybin experiment takes off

No prescription or referral is needed, but proponents hope Oregon's legalization will spark a revolution in mental health care

September 14, 2023

MAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD

Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder

August 15, 2023

Psilera Receives Allowance on Flagship Patent Securing Novel Compound Library for Mental Health Breakthroughs

Psilera emerges as industry front runner by securing coveted composition of matter patents on their vast library of drug candidates targeting psychiatry, addiction, and CNS disorders.

July 13, 2023

Beckley Retreats Advances Research to Combat Veteran Suicide Through Psychedelic Retreats

Heroic Hearts Project and Imperial College London Have Partnered with Beckley Retreats to Research Psychedelic-Assisted Therapies for Veterans

June 23, 2023

FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs

Today, the U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for potential treatment of medical conditions

June 20, 2023

PS2023: The Virtual Trip

NOW IS YOUR CHANCE TO RELIVE—OR ACCESS FOR THE FIRST TIME— PSYCHEDELIC SCIENCE 2023, THE LARGEST PSYCHEDELIC CONFERENCE IN HISTORY.

June 10, 2023

Sign Up for the Monthly Cannabis Products Insider Newsletter

February 22, 2023

The Veterans Fighting to Legalize Psychedelics

In a major shift that would modify laws set half a decade ago, states and cities around the United States are moving to legalize psychedelics for use as a medical treatment.

February 16, 2023

Twitter becomes first social media platform to allow cannabis ads in U.S.

Twitter on Wednesday became the first social media platform to allow cannabis companies to market their brands and products in the United States.The company had earlier only allowed advertising for hemp-derived CBD topical products, while other social media platforms including Facebook, Instagram and TikTok follow a "no cannabis advertising policy" as pot remains illegal at the federal level.

February 15, 2023

The rise of psychedelic retreats: the most intrepid, life-changing trip

Precisely calibrated, marrying science and shamanism, new psychedelic retreats involve the mind freediving into the deep

February 14, 2023

Schumer Meets With GOP Senators To Discuss Marijuana Legislation For New Congress

Senate Majority Leader Chuck Schumer (D-NY) held a second meeting on marijuana legislation for the new Congress on Tuesday—and this time, he convened a group of GOP senators to discuss next steps for crafting a passable bill, Senate sources tell Marijuana Moment.

January 31, 2023

How Psychedelics Can Help People, Addiction in America, and Practicing Gratitude, with Dr. Roland Griffiths

Megyn Kelly is joined by Dr. Roland Griffiths, Director of the Center for Psychedelic and Consciousness Research at the Johns Hopkins University School of Medicine, to talk about the history of psychedelic drugs and more.

January 27, 2023

A Novel Cannabinoid May Help Protect the Brain From Aging

A large variety of brain disorders associated with aging are characterized by a progressive neuronal loss, including Alzheimer’s disease and Parkinson’s disease, among others. During the past few decades, research from my laboratory on the pathological mechanism underlying these diseases has documented the critical role of long-term brain inflammation.

January 24, 2023

The FDA could approve MDMA-assisted therapy by 2024: Rick Doblin

Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on 'Kennedy.'

January 16, 2023

New Study Supports MDMA As A Treatment For PTSD

A California biopharmaceutical company has announced positive results from a clinical trial testing MDMA as a treatment for post-traumatic stress disorder, bolstering its efforts to gain federal approval for the therapeutic use of the psychedelic drug also known as ecstasy.

January 13, 2023

One In Five People Who Are Ditching Alcohol For ‘Dry January’ Say They’re Using Cannabis As An Alternative, Survey Finds

About one in five people who are abstaining from alcohol as part of “Dry January” say they’re using cannabis as an alternative to help get through the month, according to a new survey. While most observers (33 percent) of the month-long alcohol break say they’re not replacing booze with anything, 21 percent said that they’re opting for cannabis and CBD products, the poll from CivicScience found.

January 3, 2023

Legal Use of Hallucinogenic Mushrooms Begins in Oregon

On Jan. 1, Oregon became the first state to allow adult use of psilocybin “magic” mushrooms. Licensed guides will likely determine whether the program is a success.

December 18, 2022

Drug Companies Join Medical Psychedelic Movement—but Without the High

Mind-bending psychedelics including MDMA (aka “ecstasy”), “magic mushrooms” and LSD are being studied as potential treatments for depression, post-traumatic stress disorder and addiction.

November 8, 2022

What Promise Do Psychedelics Hold as Therapeutics?

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions.

October 19, 2022

Can Psychedelics Cure?

Hallucinogenic drugs—popularly called psychedelics—have been used by human societies for thousands of years. Today, scientists are taking a second look at many of these mind-altering substances–both natural and synthetic–and discovering that they can have profoundly positive clinical impacts, helping patients struggling with a range of afflictions from addiction to depression and PTSD.

December 20, 2021

Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition

Pfizer is to enter the medical cannabis industry betting on a promising cannabinoid-based bowel disease treatment.